EphA4 Antibodies

Santa Cruz Biotechnology provides a broad selection of EphA4 monoclonal antibodies for research focused on understanding EphA4 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EphA4 is a member of the Eph receptor family, which plays a significant role in cell signaling and communication during developmental processes. EphA4 regulates cell migration, adhesion, and tissue organization, making it essential for proper neuronal development and function. Research has shown that EphA4 expression levels can influence various cellular processes and pathways. Dysregulation of EphA4 has been linked to various diseases, including cancer and neurological disorders, highlighting its importance as a target for therapeutic intervention. Understanding EphA4's molecular mechanisms and signaling pathways can provide valuable insights into disease progression and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EphA4's role in health and disease.